Nicole Honigman is a proactive clinical research leader with 13+ years of experience driving Phase IIa–IV trials from feasibility through close-out across global and local settings. She currently serves as Global Study Director at AstraZeneca, where she leads cross-functional teams, oversees outsourced delivery, and steers study planning, risk‑based quality management, and inspection readiness to meet timelines, budgets, and quality standards. Previously at Alexion (AZ RDU), she led country operations and global monitoring oversight, optimizing startup, recruitment, vendor management, and CRA resourcing across complex rare disease programs. Nicole’s therapeutic expertise spans hematology, nephrology, neurology, bone metabolism, rheumatology, gastrointestinal, metabolic diseases, oncology, and infectious disease, with recent emphasis on cardiovascular trials. She is trained in project management, and recognized for disciplined TMF governance, KPI-driven performance management, and effective stakeholder communication.
